Literature DB >> 10228797

Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.

H Nakama1, M Yamamoto, N Kamijo, T Li, N Wei, A S Fattah, B Zhang.   

Abstract

BACKGROUND/AIMS: This study was carried out to assess the validity of three testing methods of immunochemical occult blood according to the number of collection times as a means for colorectal cancer screening.
METHODOLOGY: Four thousand six hundred and eleven asymptomatic individuals, who received both an immunochemical occult blood test with a three-day method and colonoscopy during a medical checkup, served as subjects for this study. For evaluation of the desirable number of sampling times, we used the results of the first day for the 1-day method, the results of the first and second days for the 2-day method, and the results of three-consecutive days for the 3-day method. Sensitivities and specificities of these three testing methods were evaluated.
RESULTS: Sensitivities and specificities for colorectal cancer were calculated to be 56% and 97% for the 1-day method, 83% and 96% for the 2-day method, and 89% and 94% for the 3-day method, respectively, showing a significant difference in sensitivity between the 1-day and the 2-day methods, as well as the 3-day method (p < 0.01), and in specificity between the 1-day as well as the 2-day and 3-day methods (p < 0.05).
CONCLUSIONS: These findings indicate that the immunochemical fecal occult blood test is useful for the diagnosis of colorectal cancer, and that 2-day testing is recommended as a means of screening for colorectal cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10228797

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  28 in total

Review 1.  Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.

Authors:  Jeffrey K Lee; Elizabeth G Liles; Stephen Bent; Theodore R Levin; Douglas A Corley
Journal:  Ann Intern Med       Date:  2014-02-04       Impact factor: 25.391

2.  Fecal immunochemical test accuracy in average-risk colorectal cancer screening.

Authors:  Vicent Hernandez; Joaquin Cubiella; M Carmen Gonzalez-Mao; Felipe Iglesias; Concepción Rivera; M Begoña Iglesias; Lucía Cid; Ines Castro; Luisa de Castro; Pablo Vega; Jose Antonio Hermo; Ramiro Macenlle; Alfonso Martínez-Turnes; David Martínez-Ares; Pamela Estevez; Estela Cid; M Carmen Vidal; Angeles López-Martínez; Elisabeth Hijona; Marta Herreros-Villanueva; Luis Bujanda; Jose Ignacio Rodriguez-Prada
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 3.  Colonic Polyps: Diagnosis and Surveillance.

Authors:  Michael B Huck; Jaime L Bohl
Journal:  Clin Colon Rectal Surg       Date:  2016-12

4.  Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.

Authors:  Motoaki Kuriyama; Jun Kato; Koji Takemoto; Sakiko Hiraoka; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

5.  Evaluation of fecal immunochemical tests for colorectal cancer screening.

Authors:  Jeanette M Daly; Camden P Bay; Barcey T Levy
Journal:  J Prim Care Community Health       Date:  2013-05-12

Review 6.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

7.  Single immunochemical fecal occult blood test for detection of colorectal neoplasia.

Authors:  Dae Kyung Sohn; Seung-Yong Jeong; Hyo Seong Choi; Seok-Byung Lim; Jin Myeong Huh; Dae-Hyun Kim; Dae Yong Kim; Young Hoon Kim; Hee Jin Chang; Kyung Hae Jung; Joong-Bae Ahn; Hyun Kyung Kim; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

8.  Sensitivity of 2-[18F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms: a large-scale analysis of 7505 asymptomatic screening individuals.

Authors:  Masau Sekiguchi; Yasuo Kakugawa; Takashi Terauchi; Minori Matsumoto; Hiroshi Saito; Yukio Muramatsu; Yutaka Saito; Takahisa Matsuda
Journal:  J Gastroenterol       Date:  2016-03-28       Impact factor: 7.527

9.  As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia.

Authors:  M Parekh; A M Fendrick; U Ladabaum
Journal:  Aliment Pharmacol Ther       Date:  2008-01-29       Impact factor: 8.171

10.  An enrichment model using regular health examination data for early detection of colorectal cancer.

Authors:  Qiang Shi; Zhaoya Gao; Pengze Wu; Fanxiu Heng; Fuming Lei; Yanzhao Wang; Qingkun Gao; Qingmin Zeng; Pengfei Niu; Cheng Li; Jin Gu
Journal:  Chin J Cancer Res       Date:  2019-08       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.